Cost-effectiveness of peer-delivered interventions for cocaine and alcohol abuse among women: A randomized controlled trial

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Ruger, Jennifer Prah ^a   Abdallah, Arbi Ben ^b   Luekens, Craig ^a   Cottler, Linda ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSTINENCE; ADULT; ALCOHOLISM; ARTICLE; BEHAVIOR THERAPY; COCAINE DEPENDENCE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE DELIVERY; HEALTH ECONOMICS; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; PEER GROUP; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ADOLESCENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; HEALTH CARE POLICY; MULTICENTER STUDY; PATIENT EDUCATION; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; ALCOHOLISM; COCAINE-RELATED DISORDERS; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HEALTH POLICY; HUMANS; PATIENT EDUCATION AS TOPIC; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84858677410     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033594     Document Type: Article

References (54)

1. U.S. Department of Health and Human Services (2009) Results from the 2008 national survey on drug use and health: national findings. NSDUH Series H-36, HHS Publication No. SMA 09-4434. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Division of Population Surveys. Available: http://www.oas.samhsa.gov/nsduh/2k8nsduh/2k8Results.pdf. Accessed 2012 February 20.
2. U.S. Department of Health and Human Services (2011) Results from the 2010 national survey on drug use and health: summary of national findings. NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration. Available: http://www.oas.samhsa.gov/nsduh/2k10nsduh/2k10Results.pdf. Accessed 2012 February 20.
3. Mokdad AH, Marks JS, Stroup DF, Gerberding JL, (2004) Actual causes of death in the United States, 2000. JAMA 291 (10): 1238-1245.
4. Office of National Drug Control Policy (2004) The Economic Costs of Drug Abuse in the United States, 1992-2002 Washington, DC Executive Office of the President Available: http://www.ncjrs.gov/ondcppubs/publications/pdf/economic_costs.pdf. Accessed 2012 February 20.
5. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, et al. (2002) A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry 59 (9): 817-824.
6. Penberthy JK, Ait-Daoud N, Vaughan M, Fanning T, (2010) Review of treatment for cocaine dependence. Curr Drug Abuse Rev 3 (1): 49-62.
7. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, et al. (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295 (17): 2003-2017.
8. Cottler LB, Compton WM, Abdallah AB, Cunningham-Williams R, Abram F, et al. (1998) Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers. Public Health Rep 113 (Suppl 1): 31-41.
9. National Institute on Drug Abuse (2008) Epidemiologic trends in drug abuse, vol. 1 Bethesda, MD Community Epidemiology Work Group Available: http://ww2.drugabuse.gov/pdf/cewg/CEWGJune08vol%201_web.pdf. Accessed 2012 February 20.
10. National Institute on Drug Abuse (2011) Epidemiologic trends in drug abuse Bethesda, MD Community Epidemiology Working Group Available: http://ww2.drugabuse.gov/pdf/cewg/CEWGJan2011_508.pdf. Accessed 2012 February 20.
11. Ruger JP, Abdallah AB, Leukens C, Cottler L, (2010) Cost-effectiveness of interventions to prevent HIV and STDs among drug-using women: a randomized controlled trial. Available at SSRN: http://ssrn.com/abstract=1619407 or http://dx.doi.org/10.2139/ssrn.1619407. Accessed 2012 Feb 26.
12. Ruger JP, Abdallah AB, Cottler L, (2010) Costs of HIV prevention among out-of-treatment drug-using women: results of a randomized controlled trial. Public Health Rep 125 (suppl 1): 83-94.
13. Zarkin GA, Bray JW, Aldridge A, Mitra D, Mills MJ, et al. (2008) Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients. Arch Gen Psychiatry 65 (10): 1214-1221.
14. Drummond C, Coulton S, James D, Godfrey C, Parrott S, et al. (2009) Effectiveness and cost-effectiveness of a stepped care intervention for alcohol use disorders in primary care: pilot study. Br J Psychiatry 195 (5): 448-456.
15. Olmstead TA, Petry NM, (2009) The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients. Drug Alcohol Depend 102: 108-115.
16. Tariq L, van den Berg M, Hoogenveen RT, van Baal PHM, (2009) Cost-effectiveness of an opportunistic screening programme and brief intervention for excessive alcohol use in primary care. PLoS One 4 (5): e5696.
17. Olmstead TA, Sindelar JL, Petry NM, (2007) Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend 87 (2-3): 175-182.
18. Sindelar J, Elbel B, Petry NM, (2007) What do we get for our money? Cost-effectiveness of adding contingency management. Addiction 102: 309-316.
19. Sindelar JL, Olmstead TA, Peirce JM, (2007) Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 102: 1463-1471.
20. UKATT Research Team (2005) Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ 331 (7516): 544-548.
21. Zarkin GA, Lindrooth RC, Demiralp B, Wechsberg W, (2001) The cost and cost-effectiveness of an enhanced intervention for people with substance abuse problems at risk for HIV. Health Serv Res 36 (2): 335-355.
22. Simpson DD, Joe GW, Fletcher BW, Hubbard RL, Anglin MD, (1999) A national evaluation of treatment outcomes for cocaine dependence. Arch Gen Psychiatry 56: 507-514.
23. Echeburua E, De Medina RB, Aizpiri J, (2009) Personality disorders among alcohol-dependent patients manifesting or not manifesting cocaine abuse: a comparative pilot study. Subst Use Misuse 44 (7): 981-989.
24. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. (1996) Cost-effectiveness in health and medicine New York Oxford University Press.
25. Cunningham RM, Cottler LB, Compton WM, (1996) Are we reaching and enrolling at-risk drug users for prevention studies? J Drug Issues 26 (3): 541-560.
26. Wechsberg WM, MacDonald BR, Dennis ML, Inciardi JA, Surratt HL, et al. (1997) The standard intervention for reduction in HIV risk behavior: protocol changes suggested by the continuing HIV/AIDS epidemic Bloomington, IL Chestnut Health Systems/Lighthouse Institute.
27. Resch S, Altice FL, Paltiel AD, (2005) Cost-effectiveness of HIV screening for incarcerated pregnant women. J Acquir Immune Defic Syndr 38 (2): 163-173.
28. Vocci FJ, Elkashef A, (2005) Pharmacotherapy and other treatments for cocaine abuse and dependence. Curr Opin Psychiatry 18 (3): 265-270.
29. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP, (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30: 205-211.
30. McKay JR, Alterman AI, Cacciola JS, Rutherford MJ, O'Brien CP, et al. (1997) Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence: initial results. J Consult Clin Psychol 65 (5): 778-788.
31. Gueorguieva R, Wu R, Pittman B, Cramer J, Rosenheck RA, et al. (2007) New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trials. Biol Psychiatry 61 (11): 1290-1295.
32. Fenwick E, O'Brien BJ, Briggs A, (2004) Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ 13: 405-415.
33. Fenwick E, Claxton K, Sculpher M, (2001) Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 10: 779-787.
34. Lothgren M, Zethraeus N, (2000) Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Economics 9: 623-630.
35. Barnett PG, Swindle RW, (1997) Cost-effectiveness of inpatient substance abuse treatment. Health Serv Res 32 (5): 615-629.
36. Weisner C, Mertens J, Parthasarathy S, Moore C, Hunkeler EM, et al. (2000) The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens. Health Serv Res 35 (4): 791-812.
37. Schumacher JE, Mennemeyer ST, Milby JB, Wallace D, Nolan K, (2002) Costs and effectiveness of substance abuse treatments for homeless persons. J Ment Health Policy Econ 5 (1): 33-42.
38. Jofre-Bonet M, Sindelar JL, Petrakis IL, Nich C, Frankforter T, et al. (2004) Cost effectiveness of disulfiram: treating cocaine use in methadone-maintained patients. J Subst Abuse Treat 26 (3): 225-232.
39. Shanahan MD, Doran CM, Digiusto E, Bell J, Lintzeris N, et al. (2006) A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addict Behav 31 (3): 371-387.
40. Warren E, Viney R, Shearer J, Shanahan M, Wodak A, et al. (2006) Value for money in drug treatment: economic evaluation of prison methadone. Drug Alcohol Depend 84 (2): 160-166.
41. Harris AH, Gospodarevskaya E, Ritter AJ, (2005) A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. Pharmacoeconomics 23 (1): 77-91.
42. Ruger JP, Weinstein MC, Hammond SK, Kearney MH, Emmons KM, (2008) Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial. Value Health 11 (2): 191-198.
43. Månsdotter AM, Rydberg MK, Wallin E, Lindholm LA, Andréasson S, (2007) A cost-effectiveness analysis of alcohol prevention targeting licensed premises. Eur J Public Health 17 (6): 618-623.
44. Schädlich PK, Brecht JG, (1998) The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study. Pharmacoeconomics 13 (6): 719-730.
45. Sindelar JL, Jofre-Bonet M, French MT, McLellan AT, (2004) Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes. Drug Alcohol Depend 73 (1): 41-50.
46. Ruger JP, (2006) Health, capability, and justice: toward a new paradigm of health ethics, policy and law. Cornell J Law Public Policy 15 (2): 101-187.
47. Ruger JP, (2009) Health and Social Justice Oxford, UK Oxford University Press.
48. Mark TL, Levit KR, Coffey RM, McKusick DR, Harwood HJ, et al. (2007) National Expenditures for Mental Health Services and Substance Abuse Treatment, 1993-2003. SAMHSA Publication No. SMA 07-4227 Rockville, MD Substance Abuse and Mental Health Services Administration.
49. Renalbusiness.com (2009) Many new ESRD patients haven't seen nephrologist. Available: http://www.renalbusiness.com/news/2009/09/many-new-esrd-patients-haven-t-seen-nephrologist.aspx. Accessed 2012 February 20.
50. United States Renal Data System (2009) USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, vol. 3 Bethesda, MD National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
51. Milby JB, Schumacher JE, Wallace D, Vuchinich R, Mennemeyer ST, et al. (2010) Effects of sustained abstinence among treated substance-abusing homeless persons on housing and employment. Am J Public Health 100 (5): 913-918.
52. Basu A, Paltiel AD, Pollack HA, (2008) Social costs of robbery and the cost-effectiveness of substance abuse treatment. Health Econ 17 (8): 927-946.
53. Sindelar JL, Olmstead TA, (2006) Illicit drugs and drug-related crime. In: Jones A, editors. The Elgar Companion to Health Economics Northampton, MA Edward Elgar Publishing pp. 83-92.
54. Ackerman JP, Riggins T, Black MM, (2010) A review of the effects of prenatal cocaine exposure among school-aged children. Pediatrics 125 (3): 554-565.